亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Outcomes of Goniotomy With or Without Secondary Intraocular Lens Implantation in Pediatric Glaucoma Following Cataract Surgery: A Prospective Pilot Study

医学 四分位间距 眼压 青光眼 前瞻性队列研究 眼科 白内障手术 继发性青光眼 人工晶状体 外科
作者
Yu Zhang,Wan Chen,Tse‐Chun Lin,Xiulan Zhang,Dennis S.C. Lam,Weirong Chen
出处
期刊:Asia-Pacific journal of ophthalmology [Lippincott Williams & Wilkins]
卷期号:12 (5): 444-450 被引量:2
标识
DOI:10.1097/apo.0000000000000637
摘要

Purpose: To report the outcomes of a 120-degree goniotomy (GT) with or without secondary intraocular lens (IOL) implantation in glaucoma following cataract surgery (GFCS). Design: Prospective, observational study. Methods: Pediatric patients with GFCS who underwent standalone 120-degree GT or 120-degree GT combined with secondary IOL implantation (GT+IOL) from March 2022 to August 2022 at the Zhongshan Ophthalmic Center were recruited. Primary outcomes were intraocular pressure (IOP) and the number of ocular hypotensive medications. A secondary outcome was the surgical success rate. Success was defined as a postoperative IOP within the range of 5–21 mm Hg. Complete and qualified successes were defined, as the above, without and with ocular hypotensive medications, respectively. Results: Thirty-two eyes of 22 patients were included. The mean age at the time of GT was 68.5 ± 29.3 months. The mean follow-up duration was 12.2 ± 2.3 months (9–15 mo). Mean IOP decreased from 30.9 ± 4.8 mm Hg on 2 (interquartile range = 1) medications at baseline to 15.8 ± 3.6 mm Hg on 0 (interquartile range = 1.5) medication at the latest visit in all eyes. The overall complete and qualified success rates were 68.8% and 90.6%, respectively. There were no significant differences in IOP, number of medications, and complete and qualified success rates between the standalone GT and GT+IOL groups at the latest follow-up at 9 months postoperatively. Conclusions: To reduce the need for additional surgery, 120-degree GT was a safe and effective surgical treatment for GFCS in children, which could be combined with secondary IOL implantation in aphakic eyes with GFCS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
蜗牛小霸王完成签到,获得积分10
7秒前
8秒前
10秒前
11秒前
rerorero18发布了新的文献求助10
14秒前
21秒前
脑洞疼应助科研通管家采纳,获得10
26秒前
唐泽雪穗应助科研通管家采纳,获得10
26秒前
26秒前
31秒前
sailingluwl完成签到,获得积分10
32秒前
32秒前
今晚喝两杯完成签到,获得积分20
36秒前
季生完成签到,获得积分10
38秒前
染东完成签到,获得积分10
43秒前
45秒前
55秒前
难过的踏歌完成签到,获得积分10
57秒前
雁塔完成签到 ,获得积分10
1分钟前
yangjoy完成签到 ,获得积分10
1分钟前
1分钟前
bobo完成签到 ,获得积分10
1分钟前
研友_Bn29bL发布了新的文献求助10
1分钟前
1分钟前
研友_Bn29bL完成签到,获得积分20
1分钟前
黄瑞发布了新的文献求助10
1分钟前
1分钟前
黄瑞完成签到,获得积分20
1分钟前
1分钟前
汉堡包应助娇气的火车采纳,获得10
1分钟前
研友_VZG7GZ应助黄瑞采纳,获得10
1分钟前
2分钟前
NexusExplorer应助ZSN采纳,获得10
2分钟前
2分钟前
科研通AI6应助科研通管家采纳,获得10
2分钟前
科研通AI2S应助科研通管家采纳,获得10
2分钟前
唐泽雪穗应助科研通管家采纳,获得10
2分钟前
852应助科研通管家采纳,获得10
2分钟前
研友_VZG7GZ应助娇气的火车采纳,获得10
2分钟前
娇气的火车完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
SOFT MATTER SERIES Volume 22 Soft Matter in Foods 1000
Zur lokalen Geoidbestimmung aus terrestrischen Messungen vertikaler Schweregradienten 1000
可见光通信专用集成电路及实时系统 500
Storie e culture della televisione 500
Selected research on camelid physiology and nutrition 500
《2023南京市住宿行业发展报告》 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4879953
求助须知:如何正确求助?哪些是违规求助? 4166788
关于积分的说明 12927209
捐赠科研通 3925467
什么是DOI,文献DOI怎么找? 2154812
邀请新用户注册赠送积分活动 1172867
关于科研通互助平台的介绍 1076882